Journal of Neuroinflammation, 2022 · DOI: https://doi.org/10.1186/s12974-022-02602-y · Published: January 1, 2022
The central nervous system (CNS) is vulnerable to mechanical damage, leading to conditions like traumatic brain injury (TBI) and spinal cord injury (SCI). These injuries often result in significant disability and high medical costs. Following the initial injury, a secondary injury occurs, extending damage to adjacent healthy cells and leading to inflammation and neuronal cell death. Therefore, controlling neuroinflammation to prevent nerve cell death is vital for treating CNS injuries. The STING pathway is activated by the presence of cytoplasmic DNA and plays a role in inflammation and cell death pathways. Understanding how STING modulates the inflammatory response in CNS injury may reveal therapeutic targets.
The cGAS-STING pathway could be a therapeutic target for CNS injury.
Development of drugs that modulate STING activity could improve neuronal and glial survival and attenuate neurological deficits.
Specific combination therapies targeting the cGAS–STING pathway may represent a promising strategy for the treatment of CNS injury.